People channel feed

Eliz­a­beth War­ren wants Gilead CEO Daniel O'­Day in the hot seat to talk drug pric­ing and com­pet­i­tive­ness

5 years ago
Coronavirus

For­mer FDA No. 2 Amy Aber­nethy re­joins Robert Califf at Google's Ver­i­ly, hop­ping aboard as clin­i­cal R&D head

5 years ago
FDA+

Q&A: Amid an M&A flur­ry at Charles Riv­er, long­time ex­ec Bir­git Gir­shick dis­cuss­es how Covid-19 has changed the game

5 years ago
Manufacturing

Ma­gen­ta's R&D head hits the ex­it just weeks af­ter read­ing out mid-stage da­ta for lead ther­a­py, eye­ing clin­ic for an­oth­er

5 years ago

Alise Re­icin re­cruits GNF vet Pe­ter Mc­Na­ma­ra to head re­search at Tim Springer's lat­est start­up

5 years ago
R&D

Black­stone en­lists a mur­der­ers' row of ad­vi­sors, in­clud­ing ex-Sanofi CEO Olivi­er Brandi­court, to steer life sci­ences biz

5 years ago
Financing

In­side Ver­tex 3.0: Can Resh­ma Ke­wal­ra­mani re­peat one of biotech's biggest suc­cess sto­ries 'a­gain and again and again'?

5 years ago
In Focus

House com­mit­tee grills Emer­gent CEO Bob Kramer over J&J vac­cine de­ba­cle, ill-timed stock sale

5 years ago
R&D

Voy­ager CEO An­dre Turenne re­signs amid set­backs, as the biotech piv­ots back to dis­cov­ery

5 years ago

Pas­sage Bio los­es two ex­ecs in one week as CFO, CMO pack their bags amid 'chang­ing need­s'

5 years ago

Lega­cies: 60 bio­phar­ma pi­o­neers over 60 who helped birth a tech rev­o­lu­tion in the mak­ing

5 years ago
Special

On the heels of a sting­ing Q1 set­back, Es­pe­ri­on's long­time cham­pi­on is ex­it­ing the helm and turn­ing the wheel over to a mar­ket­ing pro

5 years ago

Luisa Salter-Cid joins long­time Bris­tol My­ers col­lab­o­ra­tor Paul Bion­di at Flag­ship's new drug brew­ery

5 years ago

Alex­ion co-founder Stephen Squin­to is back in the game as CEO, this time for a small gene ther­a­py play­er

5 years ago
Financing

George Golumbes­ki signs on at a Eu­ro­pean spe­cial­ist VC firm with $265M to bet on ge­net­ic dis­eases

5 years ago
Financing

An Ab­b­Vie clin­i­cal vet head­ing ear­ly on­col­o­gy jumps ship to build his own team at NK cell-fo­cused biotech

5 years ago
Cell/Gene Tx

Ex-Pur­due Phar­ma chief Mark Tim­ney, named in dozens of opi­oid law­suits, nabs an­oth­er biotech CEO gig

5 years ago

Af­ter wind­ing down Quench Bio with a bold dose of hon­esty, Sam Truex finds 'per­fect fit' at At­las Ven­ture

5 years ago

Ahead of Nas­daq de­but, Saurabh Sa­ha pads out the C-suite at Centes­sa, hir­ing a top Dai­ichi Sankyo alum as CMO

5 years ago

Per­cep­tive's $310M US/Chi­na play woos new CEO from Eli Lil­ly's top-speed bam­lanivimab team

5 years ago

Q&A: Ain­drea Camp­bell goes small, step­ping away from Ap­ple to head man­u­fac­tur­ing at Zymer­gen — where am­bi­tions are big

5 years ago
Outsourcing
Manufacturing

2sev­en­ty: Nick Leschly brings a trio of top ex­ecs with him on top-speed flight from the blue­bird nest

5 years ago

Is that an­oth­er IPO in the mak­ing? Ex-No­var­tis CEO Joe Jimenez and a lead Kite play­er take up new posts at an off-the-shelf ri­val to 2 pi­o­neer­ing drugs

5 years ago

'Chang­ing the whole game of drug dis­cov­ery': Leg­endary R&D vet Roger Perl­mut­ter leaps back in­to work as a biotech CEO

5 years ago
Startups
First page Previous page 57585960616263 Next page Last page
A service from the Financial Times